The von Willebrand factor activity test measures how well von Willebrand factor helps platelets stick to an injured blood vessel and start a clot. A low result means the clotting process may be slower, especially at the first step of stopping bleeding from small blood vessels in the skin, nose, mouth, uterus, or digestive tract. This test is most often ordered when someone has easy bruising, frequent nosebleeds, heavy menstrual bleeding, prolonged bleeding after dental work, or a family history of von Willebrand disease.
vWF activity is not interpreted alone. Doctors usually compare it with von Willebrand factor antigen, factor VIII activity, the bleeding history, and sometimes platelet function or multimer testing. Mildly low results need careful interpretation because vWF levels change with blood type, pregnancy, inflammation, stress, estrogen use, illness, and age.
- vWF activity measures function, not amount. It checks how well von Willebrand factor supports platelet binding during early clot formation.
- A common adult reference range is about 50–200 IU/dL or 50–200%. Some laboratories use 55–200%, so the lab’s own range matters.
- vWF activity below 50 IU/dL is usually considered low or borderline low. Results below 30 IU/dL more strongly support von Willebrand disease.
- A low vWF activity-to-antigen ratio suggests a function problem. A ratio below about 0.7 often points toward type 2 von Willebrand disease.
- Normal PT and aPTT results do not rule out von Willebrand disease. Mild cases often need specific vWF testing despite normal screening tests.
- Heavy ongoing bleeding, black stools, fainting, or bleeding after surgery or childbirth needs urgent medical care.
Table of Contents
- What the vWF Activity Test Measures
- Normal Range and Result Levels
- Low vWF Activity and Bleeding Risk
- How vWF Activity Results Fit von Willebrand Disease Types
- Causes of Low, Borderline, or Changing vWF Activity
- Testing Preparation and Factors That Affect Accuracy
- Follow-Up Tests and Next Steps
- When to Seek Medical Care
What the vWF Activity Test Measures
The vWF activity test measures whether von Willebrand factor works well enough to help platelets attach where bleeding starts. Platelets are small blood cells that form the first plug at an injured blood vessel. Von Willebrand factor acts like a bridge between platelets and the damaged vessel wall.
This matters because many bleeding symptoms happen before the deeper clotting system has time to stabilize the clot. When vWF activity is low, a person may bleed longer from areas with many small blood vessels, such as the nose, gums, skin, uterus, and digestive tract.
The test is also called a VWF activity assay, vWF functional assay, platelet-dependent VWF activity test, or, in older reports, ristocetin cofactor activity. Different laboratories use different assay methods. Older tests often measured VWF ristocetin cofactor activity, written as VWF:RCo. Newer automated methods include VWF:GPIbM and VWF:GPIbR assays, which measure platelet-binding function more directly or with better precision in many settings.
The key point is simple: vWF antigen tells how much von Willebrand factor is present, while vWF activity tells how well it works. A person may have a low amount, poor function, or both.
Doctors often order vWF activity as part of a von Willebrand disease panel. That panel usually includes:
- vWF activity
- vWF antigen
- factor VIII activity
- sometimes vWF multimer analysis
- sometimes vWF collagen binding or genetic testing
This test helps evaluate symptoms such as:
- Frequent or prolonged nosebleeds
- Easy bruising, especially large bruises or bruises with a lump
- Heavy or prolonged menstrual bleeding
- Bleeding after dental extraction
- Bleeding after surgery, childbirth, or miscarriage
- Gum bleeding without clear dental disease
- Iron deficiency from repeated blood loss
- Family history of von Willebrand disease or unexplained bleeding
A low result does not automatically diagnose von Willebrand disease. It shows that the clotting system needs a more complete review. The bleeding history, family history, repeat testing, and related clotting markers decide the meaning.
Normal Range and Result Levels
Most laboratories report vWF activity as a percentage or as IU/dL. In practical use, these units often line up closely: 50% is usually similar to 50 IU/dL. Always compare the result with the reference interval printed on the report, because assay method and laboratory calibration change the range.
A common adult reference range is about 50–200 IU/dL, and some laboratories use 55–200%. Results near the lower limit need more care than results that are clearly normal or clearly low.
| vWF activity result | Common interpretation | What it often means clinically |
|---|---|---|
| About 50–200 IU/dL or 50–200% | Usually within the adult reference range | Von Willebrand disease is less likely if vWF antigen and factor VIII are also normal, though symptoms still matter. |
| 40–50 IU/dL | Borderline low in many labs | May reflect blood type O, mild low VWF, early or mild VWD, or temporary variation. |
| 30–50 IU/dL | Low VWF range | Bleeding history becomes very important; repeat testing and a full panel are usually needed. |
| Below 30 IU/dL | Clearly low | More strongly supports von Willebrand disease, especially with bleeding symptoms or family history. |
| Very low or undetectable | Severe deficiency pattern | Raises concern for severe VWD, especially type 3, when vWF antigen is also very low and factor VIII is reduced. |
The most useful interpretation comes from comparing vWF activity with vWF antigen. A person with type 1 von Willebrand disease usually has both activity and antigen reduced in a similar pattern. A person with type 2 von Willebrand disease often has activity that is much lower than the antigen level because the protein is present but does not work normally.
The vWF activity-to-antigen ratio helps show this difference. A ratio below about 0.7 suggests a functional defect and often leads to more testing for type 2 VWD. For example, vWF activity of 32 IU/dL with vWF antigen of 80 IU/dL gives a ratio of 0.4, which suggests a disproportionate function problem. By contrast, vWF activity of 34 IU/dL with vWF antigen of 38 IU/dL suggests a more even reduction in amount and function.
A normal result does not always end the evaluation. vWF rises during inflammation, infection, stress, exercise, pregnancy, and estrogen exposure. Someone with mild VWD may test normal during a stressful illness or late pregnancy. When symptoms strongly suggest a bleeding disorder, doctors often repeat testing when the person is well and not under a temporary influence that raises vWF.
This is one reason screening tests such as PT and aPTT have limits. A coagulation panel gives useful first clues, but normal PT and aPTT results do not exclude mild VWD.
Low vWF Activity and Bleeding Risk
Low vWF activity increases bleeding risk because platelets have more trouble forming a stable early plug. The risk is not based on the number alone. A person with vWF activity of 42 IU/dL and repeated heavy bleeding after dental work has a different risk than someone with the same result and no bleeding history.
The most typical bleeding pattern is mucocutaneous bleeding, which means bleeding from the skin and moist surfaces of the body. Common examples include:
- Nosebleeds that last more than 10 minutes or recur often
- Easy bruising with minimal injury
- Prolonged bleeding from small cuts
- Gum bleeding that seems out of proportion to brushing or dental disease
- Heavy menstrual bleeding, flooding, large clots, or anemia from periods
- Excess bleeding after dental extraction, tonsil surgery, childbirth, or other procedures
- Blood in stool or gastrointestinal bleeding in some people, especially with more severe disease
Bleeding risk rises when vWF activity is very low, when factor VIII is also low, or when the person has a strong bleeding history. Factor VIII matters because von Willebrand factor carries and protects factor VIII in the bloodstream. If vWF is very low, factor VIII may drop too, which adds a deeper clotting problem. That pattern can prolong the aPTT, although a normal aPTT still does not rule out VWD.
Heavy menstrual bleeding deserves special attention. Many people first learn they have low vWF activity after years of periods that were treated as “normal for them.” Red flags include soaking through pads or tampons every hour, needing double protection, bleeding longer than seven days, passing large clots, or developing low ferritin or anemia. A complete blood count and iron studies often help measure the effect of blood loss.
Low vWF activity does not usually cause spontaneous deep muscle or joint bleeding in mild cases. Joint and muscle bleeding are more concerning for severe VWD, very low factor VIII, hemophilia, or another significant bleeding disorder. When a person has deep tissue bleeding, the evaluation often expands to include factor assays such as factor VIII activity and sometimes additional clotting studies.
Bleeding risk also changes with the situation. A mildly low result may cause no daily symptoms but become important before surgery, childbirth, dental extraction, colonoscopy with biopsy, or injury. Planning matters. People with known low vWF activity often need a procedure plan that may include desmopressin testing, tranexamic acid, aminocaproic acid, topical measures, or vWF-containing concentrates depending on the diagnosis and procedure.
How vWF Activity Results Fit von Willebrand Disease Types
vWF activity helps separate several patterns of von Willebrand disease. The result becomes much more useful when interpreted with vWF antigen, factor VIII, platelet count, and sometimes multimer analysis.
Type 1 von Willebrand disease
Type 1 VWD is a partial quantitative deficiency. The body makes less von Willebrand factor, but the protein that is present usually works normally. In this pattern, vWF activity and vWF antigen are both reduced in a similar way.
A typical type 1 pattern might look like:
- vWF activity: 28 IU/dL
- vWF antigen: 32 IU/dL
- activity-to-antigen ratio: near normal
- factor VIII: normal or mildly reduced
Results below 30 IU/dL strongly support VWD. Results from 30–50 IU/dL often require a clear bleeding history, family history, or repeat testing to decide whether the best label is type 1 VWD or low VWF.
Low VWF
Low VWF usually refers to vWF levels around 30–50 IU/dL in a person who does not clearly fit severe inherited VWD. This range is clinically important because some people bleed more with surgery, dental work, childbirth, or menstruation. Others have few symptoms.
The term matters less than the practical plan. A person with low VWF and a meaningful bleeding history still needs documentation, procedure planning, and advice about medicines that increase bleeding risk.
Type 2 von Willebrand disease
Type 2 VWD is mainly a function problem. The body may make enough vWF antigen, but the protein does not work normally. vWF activity is often disproportionately low compared with antigen.
A typical type 2 pattern might look like:
- vWF activity: 25 IU/dL
- vWF antigen: 75 IU/dL
- activity-to-antigen ratio: 0.33
- factor VIII: variable
Type 2 has several subtypes. Type 2A and 2B often involve loss of high-molecular-weight multimers, the larger vWF forms that work best for platelet binding. Type 2M has impaired platelet binding without the same multimer loss. Type 2N mainly affects binding to factor VIII, so it can resemble mild hemophilia A.
A low platelet count may appear in type 2B because abnormal vWF can bind platelets too easily in circulation. That makes the platelet count useful when subtype 2B is possible. In that situation, platelet-focused tests such as platelet count and specialized VWD testing help guide safe treatment.
Type 3 von Willebrand disease
Type 3 VWD is the most severe inherited form. vWF antigen and activity are extremely low or undetectable, and factor VIII is often low. Bleeding may include severe mucosal bleeding, gastrointestinal bleeding, muscle bleeding, and joint bleeding.
Type 3 is uncommon, but recognizing it matters because treatment usually requires vWF-containing concentrate rather than simple observation or minor preventive steps.
Acquired von Willebrand syndrome
Acquired von Willebrand syndrome looks like VWD on lab testing but develops because of another condition rather than an inherited VWF gene change. It has been linked with conditions such as severe aortic stenosis, left ventricular assist devices, certain blood cancers, monoclonal gammopathy, autoimmune disease, hypothyroidism, and high-shear cardiovascular states.
This pattern is more likely when bleeding starts later in life without a childhood history or family history. The test results may show low activity, a low activity-to-antigen ratio, or loss of high-molecular-weight multimers.
Causes of Low, Borderline, or Changing vWF Activity
A low vWF activity result has several possible explanations. Some are inherited, some are acquired, and some reflect temporary changes around the time of the blood draw.
Inherited von Willebrand disease is the classic cause. Type 1 lowers the amount of vWF. Type 2 lowers function. Type 3 causes very severe deficiency. Family history helps, but a missing family history does not rule it out. Some relatives have mild symptoms, never had major surgery, or were never tested.
Blood type also affects results. People with blood type O tend to have lower vWF levels than people with non-O blood types. Some healthy people with blood type O have vWF activity around 40–50 IU/dL. This does not mean the result should be ignored. It means the result needs to be interpreted with symptoms, antigen level, factor VIII, and repeat testing.
Temporary increases can hide mild VWD. vWF is an acute-phase reactant, meaning it rises during physical stress and inflammation. Results may increase during:
- Infection or fever
- Recent injury
- Surgery or hospitalization
- Vigorous exercise
- Pregnancy
- Estrogen therapy or some hormonal contraceptives
- Stress from the blood draw or acute illness
- Chronic inflammatory disease
- Aging
This is one of the most common reasons a person with convincing bleeding symptoms has a normal or borderline result. Repeating the test later often gives a clearer picture.
Acquired causes may lower vWF activity or make it function poorly. Examples include severe aortic stenosis, left ventricular assist devices, monoclonal gammopathy, lymphoproliferative disorders, autoimmune disease, hypothyroidism, and some vascular malformations. These causes deserve special attention when abnormal bleeding begins in adulthood.
Medications do not usually lower vWF activity directly, but they can worsen bleeding when vWF activity is already low. Aspirin, clopidogrel, anticoagulants, high-dose nonsteroidal anti-inflammatory drugs, and some supplements with antiplatelet effects may increase bleeding tendency. A person with low vWF activity should ask a clinician before using aspirin or frequent NSAIDs for pain unless those medicines were specifically recommended.
Liver disease, kidney disease, and platelet disorders can complicate the picture. A person may have more than one reason for bleeding. For example, heavy menstrual bleeding may involve low vWF, fibroids, endometriosis, iron deficiency, medication effects, or platelet dysfunction. Good interpretation avoids blaming every symptom on one borderline lab result.
Testing Preparation and Factors That Affect Accuracy
The vWF activity test uses a blood sample, usually collected into a light-blue-top sodium citrate tube for coagulation testing. The sample must be handled carefully because clotting tests are sensitive to collection and processing problems.
Most people do not need to fast. The most important preparation is making sure the ordering clinician and laboratory know the clinical context. Tell the healthcare team about:
- Current bleeding symptoms
- Pregnancy or recent childbirth
- Recent infection, fever, surgery, injury, or intense exercise
- Estrogen use, hormonal contraception, or hormone therapy
- Blood thinners, aspirin, NSAIDs, or antiplatelet medicines
- Previous desmopressin or vWF concentrate treatment
- Family history of VWD, hemophilia, or heavy bleeding
- Blood type, if known
Timing matters. Testing during acute illness, pregnancy, or severe stress may raise vWF and make a low baseline harder to detect. Testing right after treatment with desmopressin or vWF concentrate also changes results and is only appropriate when the goal is to monitor treatment response.
Pre-analytical handling also matters. Platelet-poor plasma is often required. Some laboratories require double centrifugation and rapid freezing if the sample is sent to a reference laboratory. Poor sample handling can produce misleading values.
A single mildly low result should usually be repeated, especially if the person is not actively bleeding and no urgent procedure is planned. A single normal result may also need repeating when the bleeding history is strong. Repeat testing helps separate a stable inherited pattern from temporary variation.
The test is not a stand-alone screening tool for every person with bruising. Bruising can come from trauma, aging skin, corticosteroids, platelet problems, low platelets, liver disease, vitamin deficiencies, and medication effects. vWF activity is most helpful when the bleeding pattern fits VWD or when a procedure risk assessment requires it.
Follow-Up Tests and Next Steps
Follow-up depends on the result pattern and the bleeding story. The usual next step is not just “repeat the same test,” but to build a full clotting picture.
Common follow-up tests include:
- vWF antigen: Measures the amount of vWF protein.
- Factor VIII activity: Checks whether low vWF is reducing factor VIII stability.
- vWF activity-to-antigen ratio: Helps separate amount problems from function problems.
- vWF multimer analysis: Shows whether the large, most active vWF forms are missing.
- vWF collagen binding: Helps assess binding to collagen and may support subtype classification.
- Platelet count and platelet function testing: Looks for platelet number or function problems that can mimic VWD.
- PT, INR, and aPTT: Looks for broader clotting pathway abnormalities.
- Iron studies and CBC: Checks for anemia or iron deficiency from chronic bleeding.
- Genetic testing: Used selectively, especially for type 2, type 3, complex cases, or family planning.
The activity-to-antigen ratio is one of the most useful follow-up calculations. A normal or near-normal ratio with both values low points toward a quantitative reduction. A low ratio points toward a function defect.
Doctors may also use a bleeding assessment tool, especially in hematology clinics. This structured checklist scores bleeding symptoms such as nosebleeds, bruising, dental bleeding, surgical bleeding, postpartum bleeding, and heavy menstrual bleeding. It does not replace labs, but it makes the bleeding history more consistent and easier to interpret.
Treatment planning depends on the diagnosis, procedure, and past response. Options include:
- Desmopressin, also called DDAVP: Releases stored vWF from blood vessel lining cells in some people with type 1 VWD.
- Tranexamic acid or aminocaproic acid: Helps stabilize clots, especially for mouth, nose, dental, and menstrual bleeding.
- vWF-containing concentrates: Used for more severe VWD, some type 2 patterns, type 3 VWD, major surgery, or poor DDAVP response.
- Hormonal treatment for heavy menstrual bleeding: May reduce menstrual blood loss in selected patients.
- Local measures: Nasal care, dental packing, surgical hemostatic agents, and pressure techniques can help control site-specific bleeding.
A DDAVP trial is often done under medical supervision before relying on desmopressin for surgery or childbirth. The trial measures vWF activity, vWF antigen, and factor VIII before and after the dose to confirm that the response is strong enough and lasts long enough. DDAVP is not suitable for everyone, and it may be avoided in type 2B VWD, very young children, certain cardiovascular conditions, and people at risk for low sodium.
For procedures, the safest plan is written before the procedure date. The plan should state the diagnosis or suspected diagnosis, baseline results, treatment to use, timing of doses, target levels if needed, and who to contact for bleeding. This prevents last-minute confusion when a dentist, surgeon, obstetrician, or emergency clinician sees “low vWF activity” in the chart.
When to Seek Medical Care
A low vWF activity result deserves medical follow-up, but urgency depends on symptoms. Schedule a non-urgent appointment with a healthcare professional or hematologist when the result is low or borderline and you have a history of frequent nosebleeds, heavy periods, easy bruising, anemia, bleeding after dental work, or family history of a bleeding disorder.
Seek urgent care now for:
- Bleeding that does not stop with steady pressure
- Vomiting blood or coughing up blood
- Black, tarry stool or large amounts of blood in stool
- Severe headache, weakness, confusion, or head injury with bleeding risk
- Fainting, chest pain, shortness of breath, or signs of shock
- Heavy vaginal bleeding with dizziness, weakness, or soaking pads rapidly
- Bleeding after surgery, childbirth, miscarriage, or dental extraction that seems excessive
- Large painful swelling after injury, which may suggest deeper bleeding
Tell clinicians about the low vWF activity result before surgery, dental extraction, childbirth, biopsy, endoscopy, or starting blood thinners. Even a mild result can change the safest plan.
People with confirmed VWD or clinically important low VWF should keep a record of their diagnosis, baseline labs, treatment response, and hematology contact information. A medical alert card or phone note helps during emergencies. The most useful record includes the exact subtype if known, whether DDAVP works, whether vWF concentrate has been used, and whether any medicines should be avoided.
A low result can feel worrying, but it is also useful. It gives a reason to plan ahead, prevent avoidable bleeding, treat iron deficiency when present, and choose safer options before procedures. The goal is not just to label the result. The goal is to understand the bleeding risk in real life and create a plan that fits the person, the numbers, and the situation.
References
- Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the UKHCDO and the BSH 2024 (Guideline)
- Clinical and laboratory diagnosis of von Willebrand disease 2026 (Review)
- Von Willebrand Disease 2024 (Review)
- Diagnosing von Willebrand Disease 2024 (Official Resource)
- VWACT – Overview: von Willebrand Factor Activity, Plasma 2026 (Laboratory Reference)
- Diagnosis and treatment of von Willebrand disease in 2024 and beyond 2024 (Review)
Disclaimer
This article is educational and does not replace care from a qualified healthcare professional. vWF activity results need interpretation with your bleeding history, other clotting tests, medications, pregnancy status, and the laboratory’s own reference range. Seek urgent medical care for heavy, persistent, unexplained, or post-procedure bleeding.
